Chronic Pain Clinical Trials Safety Sleep 
The Cannigma
OCTOBER 11, 2021
of the respondents who use it to treat chronic pain, 80% of those reported using it for depression, 73% of respondents with insomnia, and 78.3% The most common health conditions among the sample group were anxiety (51.2%), chronic pain (40.9%), depression (33.1%), and insomnia/distrubed sleep (30.7%).
MMJ Recs
DECEMBER 28, 2023
From chronic pain to neurological disorders, understanding the breadth of MMJ’s applications provides a comprehensive view of its role in modern healthcare. Cannabinoids, the active compounds in marijuana, interact with the endocannabinoid system in the body, modulating pain perception and inflammation.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MMJ Recs
APRIL 1, 2024
From its anti-inflammatory properties to its ability to alleviate pain, CBD shows promise in addressing various health conditions. Studies have suggested that CBD may help manage chronic pain, reduce anxiety and depression, alleviate symptoms of epilepsy, and even aid in cancer treatment.
Canna Care Docs
OCTOBER 3, 2023
This may include opiates for chronic pain, anti-nausea medication, and even antidepressants. These symptoms include: Loss of appetite Fatigue or insomnia Nausea and vomiting Constipation Difficulty Breathing Chronic pain Weight loss General weakness of muscle A terminal illness diagnosis can immensely impact a patient and their family.
MMJ Recs
NOVEMBER 20, 2023
Therapeutic Effects of Cannabinoids Pain Relief: Perhaps one of the most recognized therapeutic effects of cannabinoids is pain relief. Both THC and CBD have demonstrated analgesic properties, making them valuable for managing chronic pain conditions such as arthritis, fibromyalgia, and cancer-related pain.
The Joint Blog
APRIL 17, 2020
Crohn’s ), chronic pain , appetite loss , issues with sleep , immune system disorders , thermoregulation problems, cancer and more. While there have been significant studies done over the years, only chronic pain, antiemesis, multiple sclerosis , and sleep have any level of evidence of cannabis effectiveness.
Veriheal
JANUARY 5, 2023
A randomized, double-blind, cross-over trial of cannabis recently published by Research Gate explored whether or not cannabidiol (CBD) — the primary non-intoxicating constituent of cannabis and hemp — improves or reduces the cannabis safety. . About the Study Into CBD’s Influence on Cannabis Safety.
Expert insights. Personalized for you.
132 
Let's personalize your content